Brind.

FDA engagement addresses unmet need of Huntington's disease, leading to Cantor Fitzgerald upgrading QURE stock due to the progress.

1 report, 1 independent Updated Jun 18

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

FDA Huntington Cantor Fitzgerald

Keep exploring

The entities involved

FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
Huntington
city in Cabell County, West Virginia, United States
- Lawmakers question Flock's data security practices as communities adopt surveillance technology for public safety in Kanawha County.Sat 13:16
- Insider transaction disclosed in a legal filing with the SEC regarding Agree Realty shares, concurrent with Huntington starting coverage.Sat 09:52
Cantor Fitzgerald
American financial services company
- SoundHound is listed on the Nasdaq stock exchange, and its CEO has outlined the company's acquisition strategy.Mon 04:01
- Analyst firm lowered price targets on Automatic Data Processing (ADP) stock on June 6, 2026.Sun 18:41

Coverage

Newest first; wire copies grouped

Jun 18benzinga.com